Thomas Kosasa insider trades: OneMedNet (ONMD) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | ONMD | ↑ Buy | 129,758 | $5.78 | $750K | Direct | Oct 13, 2026 (6d) |
| Jul 30, 2026 | ONMD | ↑ Buy | 1,449,275 | $0.69 | $1000K | Direct | Aug 7, 2026 (8d) |
| Jun 12, 2026 | ONMD | ↑ Buy | 158,730 | $0.63 | $100K | Direct | Jun 15, 2026 (3d) |
| May 18, 2026 | ONMD | ↑ Buy | 268,817 | $0.93 | $250K | Direct | May 20, 2026 (2d) |
| Sep 24, 2025 | ONMD | ↑ Buy | 1,879,871 | $0.56 | $1.0M | Direct | Nov 26, 2025 (63d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ONMD insiders
Open-market trades in the last 12 months
About Thomas Kosasa's insider trades
Thomas Kosasa is a director at OneMedNet (ONMD). Since Sep 24, 2025, Thomas has reported 5 open-market purchases worth $3.1M and no sales on SEC Form 4. In the last 12 months: 4 buys ($2.1M).
Their filings also include grants and awards (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.